Disc Medicine nabs cash, big backers and biopharma drug deal

Disc Medicine nabs cash, big backers and biopharma drug deal

Source: 
Fierce Biotech
snippet: 

Not a bad day’s work for Atlas-seeded startup Disc Medicine: It’s managed a healthy $50 million series A, led by Novo Nordisk’s VC arm, gained a new executive chair from Nimbus and nabbed a deal with AbbVie.